临床试验

NRX-101 Expanded Access

NCT：NCT05779267 · AVAILABLE

NCT编号NCT05779267

状态AVAILABLE

SponsorNeuroRx, Inc. (INDUSTRY)

First posted2023-03-22

Last updated2026-09-17

简要摘要

The purpose of this Expanded Access Treatment Protocol is to make NRX-101 available to patients who have treatment-resistant depression and who are unable to participate in, or do not have access to, the ongoing NRX-101 clinical trial. The objective of the program is to provide treatment access while monitoring safety in the context of NRX-101 administration paired with theta burst transcranial magnetic stimulation..

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。